Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.55 |
| ▸ | GGPS1 | O95749 | 1/20 | 0.44 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.43 |
| ▸ | PTGES2 | Q9H7Z7 | 1/20 | 0.43 |
| ▸ | PLA2G2A | P14555 | 3/20 | 0.43 |
| ▸ | PLA2G4A | P47712 | 3/20 | 0.43 |
| ▸ | PRKDC | P78527 | 5/20 | 0.41 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.40 |
| ▸ | JAK2 | O60674 | 1/20 | 0.39 |
| ▸ | JAK1 | P23458 | 1/20 | 0.39 |
| ▸ | TYK2 | P29597 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CASP3 | P42574 | 1/20 | 0.38 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10109885 | 1.00 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PLA2G2A | |
| SCHEMBL12960116 | 0.97 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PLA2G2A | |
| SCHEMBL10109884 | 0.96 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PRKDC | |
| SCHEMBL10109886 | 0.96 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PRKDC | |
| SCHEMBL75955 | 0.96 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PRKDC | |
| SCHEMBL30436413 | 0.96 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PRKDC | |
| SCHEMBL29405383 | 0.96 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PRKDC | |
| SCHEMBL29665202 | 0.96 | ALOX5 (0.55) | ALOX5GGPS1EPHX2PTGES2PRKDC | |
| SCHEMBL24627310 | 0.95 | ALOX5 (0.52) | ALOX5GGPS1EPHX2PTGES2PLA2G2A | |
| SCHEMBL18329382 | 0.95 | ALOX5 (0.52) | ALOX5GGPS1EPHX2PTGES2PLA2G2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9087997-B2 | Aromatic amine derivative and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2015-07-21 | — | — | US | disclosed |
| US-8703304-B2 | Aromatic amine derivative and organic electroluminescence device | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-22 | — | — | US | disclosed |
| US-20140061630-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2014-03-06 | — | — | US | disclosed |
| US-20120161119-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2012-06-28 | — | — | US | disclosed |
| US-20100001636-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120161119-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | TYR, TERF2, SAT1 | ALOX5 3505/4885GGPS1 2974/4885EPHX2 1655/4885 |
| US-20100001636-A1 | AROMATIC AMINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE | TYR, TERF2, SAT1 | ALOX5 3311/4885GGPS1 2901/4885EPHX2 1561/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.